first-line icis in advanced non-clear cell rcc
Published 3 years ago • 134 plays • Length 11:18Download video MP4
Download video MP3
Similar videos
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
1:17
treating non-clear cell renal cell carcinoma patients
-
1:06
promising tki-ici combinations for non-clear cell rcc
-
1:20
promising results of cabozantinib plus nivolumab in non-clear cell rcc
-
0:53
unanswered questions in the management of clear cell rcc
-
1:02
non-clear cell sarcamatoid kidney cancer treatment updates
-
1:34
unmet needs in the treatment of renal cell carcinoma
-
38:21
three big things in advanced/high risk kidney cancer | with rana mckay and lewis au
-
1:10
dr. mcdermott on the promise of pembrolizumab in non-clear cell rcc
-
5:29
first- and second-line treatments for locally advanced renal cell carcinoma
-
0:49
clear: lenvatinib and pembrolizumab in advanced renal cell carcinoma
-
39:36
management of first line advanced rcc in era of immuno-oncology
-
1:14
dr. jonasch on single-agent pembrolizumab in non-clear cell rcc
-
0:53
the role of icis in the adjuvant setting for rcc
-
1:21
clinical trials investigating overcoming resistance to icis for rcc
-
3:36
first-line treatment of poor-risk metastatic renal cell carcinoma
-
1:48
what is the best second-line treatment of advanced renal cell carcinoma (rcc)?
-
3:47
other clinical trials in renal cell carcinoma
-
12:07
evidence in first-line metastatic renal cell carcinoma